GHB receptor
The γ-hydroxybutyrate (GHB) receptor (GHBR), originally identified as GPR172A, is an excitatory G protein-coupled receptor (GPCR) that binds the neurotransmitter and psychoactive drug γ-hydroxybutyric acid (GHB).
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
The γ-hydroxybutyrate (GHB) receptor (GHBR), originally identified as GPR172A, is an excitatory G protein-coupled receptor (GPCR) that binds the neurotransmitter and psychoactive drug γ-hydroxybutyric acid (GHB). As solute carrier family 52 member 2 (SLC52A2), it is also a transporter for riboflavin.
History
The existence of a specific GHB receptor was predicted by observing the action of GHB and related compounds that primarily act on the GABA B receptor, but also exhibit a range of effects which were found not to be produced by GABA B activity, and so were suspected of being produced by a novel and at the time unidentified receptor target. Following the discovery of the "orphan" G-protein coupled receptor GPR172A, it was subsequently found to be the GHB receptor whose existence had been previously predicted.
The rat GHB receptor was first cloned and characterised in 2003, followed by the human receptor in 2007. Due to its many functions, this gene has a history of multiple discoveries.
In 2002, data mining in the human genome found an incorrectly spliced form of this protein with eight transmembrane helices, and due to the presence of a G-protein binding site, it was correctly assumed to be a GPCR (as GCPR41). In 2003, it was first identified in its 11-transmembrane-helix full length, as a receptor for porcine endogenous retrovirus.
The same protein was later identified as the GHB receptor in 2007. In 2009, it was identified as a riboflavin transporter, and sorted into SLC family 52 due to sequence similarity. The authors of the 2009 study were not aware of the 2007 study showing that it actually does function as a GPCR.
Agonists
3-Hydroxycyclopent-1-enecarboxylic acid (HOCPCA) 4-(p-Chlorobenzyl)-GHB Aceburic acid γ-Hydroxybutyric acid (GHB) γ-Hydroxyvaleric acid (GHV; 4-methyl-GHB) NCS-356 (4-(4-chlorophenyl)-4-hydroxy-but-2-enoic acid, CAS# 430440-66-7) NCS-435 (4-(p-methoxybenzyl)-GHB) trans-Hydroxycrotonic acid (T-HCA) UMB66 UMB68 UMB72 UMB86
Antagonists
Gabazine (SR-95531) NCS-382
Unknown/unclear
Amisulpride Levosulpiride Prochlorperazine (R)-4-[4′-(2-Iodobenzyloxy)phenyl]-GHB Sulpiride Sultopride
Text derived from https://en.wikipedia.org/w/index.php?oldid=1378108060 under CC BY-SA 4.0; modifications have been made.